Warning letters, 483s, Recalls, Import Alerts, Audit observations
SCYNEXIS issued the recall of 2 lots of BREXAFEMME (ibrexafungerp tablets) due to Potential for
Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company announced approval of Exxuaâ„¢ (gepirone hydrochloride extended-release tablets)
Florida based VistaPharm LLC is recalling in US one lot of ulcer treatment drug Sucralfate
In the guidance FDA describes use of alternative tools to assess manufacturing facilities identified in
FDA has raised concerns about therapeutic equivalence of Tacrolimus capsules of Accord Healthcare to
Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL is indicated for the prophylaxis of
Abbot recalls all batches of Digene Gel of all flavours (Mint, Orange, Mix fruit flavours)
USFDA has eliminated the REMS for Lotronex (alosetron hydrochloride) and approved generics. Alosetron hydrochloride is
USFDA has announced funding opportunity for FDA Orphan Products Clinical Trials Grant Program. The deadline
Bottles of Digoxin Tablets, USP 0.125mg are incorrectly labelled and contain Digoxin Tablets USP, 0.25mg
